Home › Atopic Dermatitis (Eczema) › Nevada
Pag-aaral pangklinika para sa Atopic Dermatitis (Eczema) sa Nevada
6 pag-aaral para sa Atopic Dermatitis (Eczema) ang naghahanap ng mga kalahok sa mga site sa Nevada.
Mga Lungsod sa Nevada
Opisyal na teksto ng pag-aaral (English)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Las Vegas Dermatology- Site Number : 8400002, Las Vegas
Nagre-recruitObservasyonal na pag-aaral
Edad 12 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07290803Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Las Vegas
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07298395Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- Advanced Dermatology and Cosmetic Surgery - Henderson, Henderson
- Las Vegas Dermatology, Las Vegas
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 89 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07645820A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Skin Cancer and Dermatology Institute, Reno
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599813A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Las Vegas Dermatology /ID# 265801, Las Vegas
- Skin Cancer And Dermatology Institute (Scdi) - Reno /ID# 263771, Reno
Nagre-recruitPhase 3
Edad 18 hanggang 63 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06389136Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 8848, Las Vegas
Nagre-recruitObservasyonal na pag-aaral
Edad 12 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT06988605Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.